{"id":97777,"date":"2021-10-01T07:14:00","date_gmt":"2021-10-01T05:14:00","guid":{"rendered":"http:\/\/rss.nova-institut.net\/public.php?url=https%3A%2F%2Fwww.biofuelsdigest.com%2Fbdigest%2F2021%2F09%2F20%2Fspider-silk-and-collagen-fibers-firm-raises-700000%2F"},"modified":"2021-10-01T11:16:14","modified_gmt":"2021-10-01T09:16:14","slug":"3d-biofibr-inc-raises-new-capital-to-scale-up-manufacturing-in-an-oversubscribed-round","status":"publish","type":"post","link":"https:\/\/renewable-carbon.eu\/news\/3d-biofibr-inc-raises-new-capital-to-scale-up-manufacturing-in-an-oversubscribed-round\/","title":{"rendered":"3D BioFibR Inc. Raises New Capital to Scale Up Manufacturing in an Oversubscribed Round"},"content":{"rendered":"\n\n\n

Participants in this capital raise included further investments from current investors, including Concrete Ventures<\/a>, as well as new investors, including Globalive Capital<\/a>.<\/strong><\/p>\n\n\n\n

\u201cWe appreciate the continued confidence our investors have in the Company\u2019s ability to advance our proprietary biofibre manufacturing process,\u201d said Kevin Sullivan, CEO of 3D BioFibR. \u201cAs we continue to de-risk our manufacturing platform, our focus is now shifting to a higher level of engagement with industry to secure commercial partnerships, with our first focus on the tissue culture and tissue engineering applications.\u201d<\/p>\n\n\n\n

3D BioFibR Inc. was incorporated in July of 2020. The Company closed its first round of financing on October 19, 2020, raising $550,000. These funds were used to successfully demonstrate that their proprietary biofiber manufacturing process works well for diverse sets of cell types used in a range of biocomposite applications. Funds from this current round of financing will allow the Company to focus on optimizing the automation of its manufacturing process to be ready for first market sales in the second half of 2022.<\/p>\n\n\n\n

\u201cOur unique dry spinning manufacturing process can generate high quality collagen scaffolds that are ideal for 3D cell culture and tissue-engineering applications,\u201d said Dr. John Frampton, Chief Scientific Officer at 3D BioFibR. \u201cIt is exciting to see the transition from a lab based process to an automated system of production. These advancements will enable us to meet the market need for consistent, high quality products at commercial scale production levels.\u201d<\/p>\n\n\n\n

\u201cWe are excited to see 3D BioFibR producing collagen and spider silk fibres at a scale and quantity that no other commercial process can match,\u201d said Patrick Hankinson, Partner at Concrete Ventures. \u201cThe team at 3D BioFibR has real potential to become a best-in-class biofibre manufacturer of premium products for use in tissue culture and medical applications, as well as in the performance textile industry.\u201d<\/p>\n\n\n\n

<\/p>\n\n\n\n

About 3D BioFibR Inc.<\/strong><\/h3>\n\n\n\n

3D BioFibR produces naturally sourced, high value biofibers, such as collagen and spider silk, for potential use in biomedical engineering, green textiles, defense, and aerospace applications. The\u00a0Company\u2019s\u00a0proprietary dry-spinning process is faster than current manufacturing processes and preserves the natural properties of the biofibre proteins. 3D BioFibR is refining its large-scale production of\u00a0CollaFibRTM, a\u00a0strong, high-quality collagen fibre, to be weaved into commercial products for the 3D tissue culture and tissue engineering market.<\/p>\n","protected":false},"excerpt":{"rendered":"

In Nova Scotia, a startup developing fibers from collagen and spider silk has raised $700,000 in an …<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","nova_meta_subtitle":"Biofibre manufacturing company has raised over $700,000 which will be used to scale-up manufacturing capabilities of their collagen and spider silk fibres","footnotes":""},"categories":[5572],"tags":[10588,11286,5838,12351,11877,13831],"supplier":[19116],"class_list":["post-97777","post","type-post","status-publish","format-standard","hentry","category-bio-based","tag-3dprinting","tag-biocomposites","tag-bioeconomy","tag-medicaldevices","tag-naturalfibres","tag-spidersilk","supplier-3d-biofibr-inc"],"_links":{"self":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/97777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/comments?post=97777"}],"version-history":[{"count":0,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/97777\/revisions"}],"wp:attachment":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/media?parent=97777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/categories?post=97777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/tags?post=97777"},{"taxonomy":"supplier","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/supplier?post=97777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}